Conifex secures up to $30 million Canada tariff loan to sustain operations amid lumber market downturn
Bitget2026/09/18 18:03Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Conifex Timber secured up to $30 million Government of Canada repayable loan under the Large Enterprise Tariff Loan program.
- Funding targets liquidity to sustain operations during disrupted lumber markets, supporting plans to restore two-shift production at Mackenzie sawmill.
- Facility carries a 7-year term, market-based interest rate, secured by substantially all property, with mixed ranking versus existing secured lenders.
- Existing lumber lender agreed to reimburse up to $11 million of capital spending aimed at improving Mackenzie mill performance and EBITDA.
- Financing includes planned warrant issuance to CEEFC, new PenderFund warrants, and an extension of PenderFund’s outstanding warrants to Jan. 17, 2031.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conifex Timber Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609181402PRIMZONEFULLFEED9829747) on September 18, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like


BTC market cap briefly dropped out of the top 15 global assets
AiCoin•2026/11/15 04:37

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit
An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.
智通财经•2026/11/15 04:01

Crypto prices
MoreBitcoin
BTC
$64,403.51
-4.37%
Ethereum
ETH
$1,790.93
-5.95%
Tether USDt
USDT
$0.9994
+0.04%
BNB
BNB
$591.34
-4.34%
USDC
USDC
$0.9997
-0.02%
XRP
XRP
$0.9603
-3.36%
Solana
SOL
$70.36
-6.94%
TRON
TRX
$0.3073
-1.73%
Hyperliquid
HYPE
$65.52
-5.91%
Zcash
ZEC
$898
-1.81%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now